Skip to main content

Robenz

This treatment applies to the following species:
Company: Zoetis

Robenidine Hydrochloride

Type A Medicated Article

Coccidiostat

Active Drug Ingredient

Robenidine hydrochloride 30 grams per pound (6.6%) in a carrier suitable for incorporation in feed.

For use in manufacturing medicated feeds only

Robenz Indications

Broiler Chickens

As an aid in the prevention of coccidiosis caused by Eimeria mivati, E. brunetti, E. tenella, E. acervulina, E. maxima and E. necatrix in broiler chickens only.

Use Directions

Mix 1 pound of Robenz® Type A Medicated Article in one ton of feed to provide 30 grams per ton (0.0033%) robenidine hydrochloride concentration in feed. Feed continuously as the sole ration.

Robenz Caution

Type C feeds containing Robenz robenidine hydrochloride must be fed within 50 days from the date of manufacture. Do not use this product in Type B or C medicated feeds containing bentonite.

Warning

Do not feed to chickens producing eggs for food.

Withdraw 5 days prior to slaughter.

Note

Manufacture of Type B and C feeds from this product requires a medicated feed mill license.

Labels for feeds containing Robenz must contain appropriate indications, limitations and warnings as well as required feed ingredient information.

Restricted Drug (California) - Use Only as Directed.

Not for human use.

Store below 25°C (77°F), excursions permitted to 37°C (99°F).

Approved by FDA under NADA # 048-486

Manufactured by: Zoetis LLC, Salisbury, MD 21801

Distributed by: Zoetis Inc., Kalamazoo, MI 49007

Product of Spain

Net wt

 

50 LB (22.68 kg)

40027288

CPN: 3690421.1

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone:   269-359-4414
Customer Service:   888-963-8471
Website:   www.zoetis.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Animalytix

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27